Advanced Therapy Medicinal Products CDMO Market is expected to expand at a CAGR of 12.0% from 2021 to 2028
Advanced Therapy Medicinal Products CDMO Industry Overview The global advanced therapy medicinal products CDMO market size is expected to reach USD 12.9 billion by 2028, according to the new report of Grand View Research, Inc. It is expected to expand at a CAGR of 12.0% from 2021 to 2028. The advanced therapy medicinal products are a group of biological products for human use that involve gene therapy products, cell therapy products, and tissue-engineered products. The growth of the market is credited to the increasing clinical trials of ATMP and the rising awareness and belief among researchers regarding the benefits of advanced therapy. The COVID-19 pandemic has significantly disrupted the cell and gene therapy industry due to the complexity in the manufacturing process. Advanced Therapy Medicinal Product CDMO Market Segmentation Grand View Research has segmented the global advanced therapy medicinal products CDMO market on...